The (52-96) C-terminal Domain of Vpr Stimulates HIV-1 IN-mediated Homologous Strand Transfer of Mini-viral DNA

Overview

Journal Nucleic Acids Res

Publisher Oxford University Press

Specialty Biochemistry

Date 2003 May 9

PMID 12736319

Citations 13

Authors

Julien Bischerour

Patrick Tauc

Herve Leh

Hugues de Rocquigny

Bernard Roques

Jean-Francois Mouscadet

Affiliations

Soon will be listed here.

Abstract

Viral integrase (IN) and Vpr are both components of the human immunodeficiency virus type 1 (HIV-1) pre-integration complex. To investigate whether these proteins interact within this complex, we investigated the effects of Vpr and its subdomains on IN activity in vitro. When a 21mer oligonucleotide was used as a donor and acceptor, both Vpr and its C-terminal DNA-binding domain [(52-96)Vpr] inhibited the integration reaction, whereas the (1-51)Vpr domain did not affect IN activity. Steady-state fluorescence anisotropy showed that both full-length and (52-96)Vpr bind to the short oligonucleotide, thereby extending previous observations with long DNA. The concentrations of the two proteins required to inhibit IN activity were consistent with their affinities for the oligonucleotide. The use of a 492 bp mini-viral substrate confirmed that Vpr can inhibit the IN-mediated reaction. However, the activity of (52-96)Vpr differed notably since it stimulated specifically integration events involving two homologous mini-viral DNAs. Order of addition experiments indicated that the stimulation was maximal when IN, (50-96)Vpr and the mini-viral DNA were allowed to form a complex. Furthermore, in the presence of (50-96)Vpr, the binding of IN to the mini-viral DNA was dramatically enhanced. Taken together, these data suggest that (52-96)Vpr stimulates the formation of a specific complex between IN and the mini-viral DNA.

Citing Articles

HIV-1 Integrase-Targeted Short Peptides Derived from a Viral Protein R Sequence.

Zhao X, Metifiot M, Kiselev E, Kessl J, Maddali K, Marchand C Molecules. 2018; 23(8).

PMID: 30049955 PMC: 6222646. DOI: 10.3390/molecules23081858.

HIV Genome-Wide Protein Associations: a Review of 30 Years of Research.

Li G, De Clercq E Microbiol Mol Biol Rev. 2016; 80(3):679-731.

PMID: 27357278 PMC: 4981665. DOI: 10.1128/MMBR.00065-15.

Inhibiting the HIV integration process: past, present, and the future.

Di Santo R J Med Chem. 2013; 57(3):539-66.

PMID: 24025027 PMC: 3926363. DOI: 10.1021/jm400674a.

Cell-permeable stapled peptides based on HIV-1 integrase inhibitors derived from HIV-1 gene products.

Nomura W, Aikawa H, Ohashi N, Urano E, Metifiot M, Fujino M ACS Chem Biol. 2013; 8(10):2235-44.

PMID: 23898787 PMC: 7577350. DOI: 10.1021/cb400495h.

HIV integrase inhibitors: 20-year landmark and challenges.

Metifiot M, Marchand C, Pommier Y Adv Pharmacol. 2013; 67:75-105.

PMID: 23885999 PMC: 7569752. DOI: 10.1016/B978-0-12-405880-4.00003-2.

References

de Rocquigny H, Caneparo A, Delaunay T, Bischerour J, Mouscadet J, Roques B . Interactions of the C-terminus of viral protein R with nucleic acids are modulated by its N-terminus. Eur J Biochem. 2000; 267(12):3654-60. DOI: 10.1046/j.1432-1327.2000.01397.x. View

Kichler A, Pages J, Leborgne C, Druillennec S, Lenoir C, Coulaud D . Efficient DNA transfection mediated by the C-terminal domain of human immunodeficiency virus type 1 viral protein R. J Virol. 2000; 74(12):5424-31. PMC: 112026. DOI: 10.1128/jvi.74.12.5424-5431.2000. View

Depienne C, Roques P, Creminon C, Fritsch L, Casseron R, Dormont D . Cellular distribution and karyophilic properties of matrix, integrase, and Vpr proteins from the human and simian immunodeficiency viruses. Exp Cell Res. 2000; 260(2):387-95. DOI: 10.1006/excr.2000.5016. View

Brodin P, Pinskaya M, Buckle M, Parsch U, Romanova E, Engels J . Disruption of HIV-1 integrase-DNA complexes by short 6-oxocytosine-containing oligonucleotides. Biochemistry. 2002; 41(5):1529-38. DOI: 10.1021/bi015732y. View

Agostini I, Popov S, Hao T, Li J, Dubrovsky L, Chaika O . Phosphorylation of Vpr regulates HIV type 1 nuclear import and macrophage infection. AIDS Res Hum Retroviruses. 2002; 18(4):283-8. DOI: 10.1089/088922202753472856. View

Sinha S, Pursley M, Grandgenett D . Efficient concerted integration by recombinant human immunodeficiency virus type 1 integrase without cellular or viral cofactors. J Virol. 2002; 76(7):3105-13. PMC: 136053. DOI: 10.1128/jvi.76.7.3105-3113.2002. View

Wecker K, Morellet N, Bouaziz S, Roques B . NMR structure of the HIV-1 regulatory protein Vpr in H2O/trifluoroethanol. Comparison with the Vpr N-terminal (1-51) and C-terminal (52-96) domains. Eur J Biochem. 2002; 269(15):3779-88. DOI: 10.1046/j.1432-1033.2002.03067.x. View

Fujiwara T, Mizuuchi K . Retroviral DNA integration: structure of an integration intermediate. Cell. 1988; 54(4):497-504. DOI: 10.1016/0092-8674(88)90071-2. View

Brown P, Bowerman B, Varmus H, Bishop J . Retroviral integration: structure of the initial covalent product and its precursor, and a role for the viral IN protein. Proc Natl Acad Sci U S A. 1989; 86(8):2525-9. PMC: 286949. DOI: 10.1073/pnas.86.8.2525. View

10.

Cohen E, Terwilliger E, Jalinoos Y, Proulx J, Sodroski J, Haseltine W . Identification of HIV-1 vpr product and function. J Acquir Immune Defic Syndr (1988). 1990; 3(1):11-8. View

11.

Ellison V, ABRAMS H, Roe T, Lifson J, Brown P . Human immunodeficiency virus integration in a cell-free system. J Virol. 1990; 64(6):2711-5. PMC: 249450. DOI: 10.1128/JVI.64.6.2711-2715.1990. View

12.

Cohen E, Dehni G, Sodroski J, Haseltine W . Human immunodeficiency virus vpr product is a virion-associated regulatory protein. J Virol. 1990; 64(6):3097-9. PMC: 249501. DOI: 10.1128/JVI.64.6.3097-3099.1990. View

13.

Heinzinger N, Bukrinsky M, Haggerty S, Ragland A, Kewalramani V, Lee M . The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc Natl Acad Sci U S A. 1994; 91(15):7311-5. PMC: 44389. DOI: 10.1073/pnas.91.15.7311. View

14.

Kondo E, Mammano F, Cohen E, Gottlinger H . The p6gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous viral particles. J Virol. 1995; 69(5):2759-64. PMC: 188969. DOI: 10.1128/JVI.69.5.2759-2764.1995. View

15.

Goodarzi G, Im G, Brackmann K, Grandgenett D . Concerted integration of retrovirus-like DNA by human immunodeficiency virus type 1 integrase. J Virol. 1995; 69(10):6090-7. PMC: 189505. DOI: 10.1128/JVI.69.10.6090-6097.1995. View

16.

Jowett J, Planelles V, Poon B, Shah N, Chen M, Chen I . The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle. J Virol. 1995; 69(10):6304-13. PMC: 189529. DOI: 10.1128/JVI.69.10.6304-6313.1995. View

17.

He J, Choe S, Walker R, Di Marzio P, MORGAN D, Landau N . Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J Virol. 1995; 69(11):6705-11. PMC: 189580. DOI: 10.1128/JVI.69.11.6705-6711.1995. View

18.

Wang L, Mukherjee S, Jia F, Narayan O, Zhao L . Interaction of virion protein Vpr of human immunodeficiency virus type 1 with cellular transcription factor Sp1 and trans-activation of viral long terminal repeat. J Biol Chem. 1995; 270(43):25564-9. DOI: 10.1074/jbc.270.43.25564. View

19.

Gallay P, Swingler S, Song J, Bushman F, Trono D . HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase. Cell. 1995; 83(4):569-76. DOI: 10.1016/0092-8674(95)90097-7. View

20.

Bouhamdan M, Benichou S, Rey F, Navarro J, Agostini I, Spire B . Human immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase DNA repair enzyme. J Virol. 1996; 70(2):697-704. PMC: 189869. DOI: 10.1128/JVI.70.2.697-704.1996. View